Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-cash Items (2018 - 2024)

OptimizeRx (OPRX) has disclosed Non-cash Items for 7 consecutive years, with $10000.0 as the latest value for Q4 2024.

  • Quarterly Non-cash Items fell 99.04% to $10000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $10000.0 through Dec 2024, down 99.04% year-over-year, with the annual reading at $10000.0 for FY2024, 99.04% down from the prior year.
  • Non-cash Items hit $10000.0 in Q4 2024 for OptimizeRx, down from $4.1 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $4.1 million in Q3 2024 to a low of $10000.0 in Q4 2024.
  • Historically, Non-cash Items has averaged $892395.8 across 5 years, with a median of $324455.0 in 2022.
  • Biggest five-year swings in Non-cash Items: soared 566.62% in 2023 and later crashed 99.04% in 2024.
  • Year by year, Non-cash Items stood at $1.2 million in 2020, then crashed by 93.55% to $78334.0 in 2021, then soared by 100.31% to $156910.0 in 2022, then skyrocketed by 566.62% to $1.0 million in 2023, then tumbled by 99.04% to $10000.0 in 2024.
  • Business Quant data shows Non-cash Items for OPRX at $10000.0 in Q4 2024, $4.1 million in Q3 2024, and $492000.0 in Q1 2024.